X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with Divis Laboratories - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs DIVIS LABORATORIES - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA DIVIS LABORATORIES ABBOTT INDIA/
DIVIS LABORATORIES
 
P/E (TTM) x 43.5 28.9 150.5% View Chart
P/BV x 10.9 5.0 217.0% View Chart
Dividend Yield % 0.6 1.0 62.4%  

Financials

 ABBOTT INDIA   DIVIS LABORATORIES
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-16
DIVIS LABORATORIES
Mar-17
ABBOTT INDIA/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs6,0151,222 492.2%   
Low Rs3,707784 472.8%   
Sales per share (Unadj.) Rs1,236.9153.1 807.9%  
Earnings per share (Unadj.) Rs122.239.9 305.9%  
Cash flow per share (Unadj.) Rs129.044.6 289.2%  
Dividends per share (Unadj.) Rs35.0010.00 350.0%  
Dividend yield (eoy) %0.71.0 72.2%  
Book value per share (Unadj.) Rs521.2201.8 258.3%  
Shares outstanding (eoy) m21.25265.47 8.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.96.6 60.0%   
Avg P/E ratio x39.825.1 158.4%  
P/CF ratio (eoy) x37.722.5 167.6%  
Price / Book Value ratio x9.35.0 187.6%  
Dividend payout %28.625.0 114.4%   
Avg Mkt Cap Rs m103,296266,266 38.8%   
No. of employees `0003.09.7 30.4%   
Total wages/salary Rs m3,3704,687 71.9%   
Avg. sales/employee Rs Th8,891.84,175.0 213.0%   
Avg. wages/employee Rs Th1,140.0481.5 236.8%   
Avg. net profit/employee Rs Th878.31,089.3 80.6%   
INCOME DATA
Net Sales Rs m26,28440,643 64.7%  
Other income Rs m504749 67.4%   
Total revenues Rs m26,78941,392 64.7%   
Gross profit Rs m3,66514,460 25.3%  
Depreciation Rs m1441,233 11.7%   
Interest Rs m823 35.8%   
Profit before tax Rs m4,01713,953 28.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,4213,349 42.4%   
Profit after tax Rs m2,59610,604 24.5%  
Gross profit margin %13.935.6 39.2%  
Effective tax rate %35.424.0 147.4%   
Net profit margin %9.926.1 37.9%  
BALANCE SHEET DATA
Current assets Rs m14,44640,105 36.0%   
Current liabilities Rs m4,7256,595 71.6%   
Net working cap to sales %37.082.5 44.9%  
Current ratio x3.16.1 50.3%  
Inventory Days Days51119 43.4%  
Debtors Days Days2081 24.2%  
Net fixed assets Rs m1,11319,995 5.6%   
Share capital Rs m213531 40.0%   
"Free" reserves Rs m10,80853,043 20.4%   
Net worth Rs m11,07653,574 20.7%   
Long term debt Rs m00-   
Total assets Rs m16,24161,585 26.4%  
Interest coverage x497.0618.4 80.4%   
Debt to equity ratio x00-  
Sales to assets ratio x1.60.7 245.2%   
Return on assets %16.017.3 92.9%  
Return on equity %23.419.8 118.4%  
Return on capital %36.326.1 139.3%  
Exports to sales %0.60-   
Imports to sales %12.625.2 50.1%   
Exports (fob) Rs m162NA-   
Imports (cif) Rs m3,32210,259 32.4%   
Fx inflow Rs m26835,384 0.8%   
Fx outflow Rs m3,92710,399 37.8%   
Net fx Rs m-3,65924,985 -14.6%   
CASH FLOW
From Operations Rs m2,51411,493 21.9%  
From Investments Rs m-800-11,372 7.0%  
From Financial Activity Rs m-803-93 862.4%  
Net Cashflow Rs m91228 3,210.9%  

Share Holding

Indian Promoters % 0.0 52.0 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 11.8 66.9%  
FIIs % 0.1 19.0 0.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 17.2 99.4%  
Shareholders   18,270 31,796 57.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   PIRAMAL ENTERPRISES  NOVARTIS  PANACEA BIOTECH  DR. REDDYS LAB  GSK PHARMA  

Compare ABBOTT INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes Marginally Lower; Capital Goods & Realty Stocks Fall(Closing)

Indian share markets witnessed selling pressure in the final hour of trade to finish just below the dotted line. At the closing bell, the BSE Sensex closed lower by 71 points.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Feb 20, 2018 03:35 PM

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS